Your browser doesn't support javascript.
loading
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020.
Spiteri, Gianfranco; Fielding, James; Diercke, Michaela; Campese, Christine; Enouf, Vincent; Gaymard, Alexandre; Bella, Antonino; Sognamiglio, Paola; Sierra Moros, Maria José; Riutort, Antonio Nicolau; Demina, Yulia V; Mahieu, Romain; Broas, Markku; Bengnér, Malin; Buda, Silke; Schilling, Julia; Filleul, Laurent; Lepoutre, Agnès; Saura, Christine; Mailles, Alexandra; Levy-Bruhl, Daniel; Coignard, Bruno; Bernard-Stoecklin, Sibylle; Behillil, Sylvie; van der Werf, Sylvie; Valette, Martine; Lina, Bruno; Riccardo, Flavia; Nicastri, Emanuele; Casas, Inmaculada; Larrauri, Amparo; Salom Castell, Magdalena; Pozo, Francisco; Maksyutov, Rinat A; Martin, Charlotte; Van Ranst, Marc; Bossuyt, Nathalie; Siira, Lotta; Sane, Jussi; Tegmark-Wisell, Karin; Palmérus, Maria; Broberg, Eeva K; Beauté, Julien; Jorgensen, Pernille; Bundle, Nick; Pereyaslov, Dmitriy; Adlhoch, Cornelia; Pukkila, Jukka; Pebody, Richard; Olsen, Sonja.
Afiliação
  • Spiteri G; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Fielding J; World Health Organisation Regional Office for Europe, Copenhagen, Denmark.
  • Diercke M; Robert Koch Institute, Berlin, Germany.
  • Campese C; Santé Publique France - Direction des maladies infectieuses, Saint-Maurice, France.
  • Enouf V; Centre national de référence Virus des infections respiratoires, dont la grippe, Institut Pasteur, Paris, France.
  • Gaymard A; Centre national de référence Virus des infections respiratoires, dont la grippe, Hospices civils de Lyon, Lyon, France.
  • Bella A; Istituto Superiore di Sanita, Rome, Italy.
  • Sognamiglio P; Istituto Nazionale Malattie Infettive Lazzaro Spallanzani, Rome, Italy.
  • Sierra Moros MJ; Coordination Centre for Health Alerts and Emergencies. Spanish Ministry of Health, Madrid, Spain.
  • Riutort AN; Servicio de Epidemiología, Dirección General de Salut Pública, Islas Baleares, Spain.
  • Demina YV; Federal Service for Surveillance on Consumer Rights Protection and Human Well-being (Rospotrebnadzor), Moscow, Russia.
  • Mahieu R; Department of Infectious Disease Prevention and Control, Common Community Commission, Brussels-Capital Region, Brussels, Belgium.
  • Broas M; Chief Physician, Infection control unit, Lapland Hospital District, Rovaniemi, Finland.
  • Bengnér M; County Medical Officer, Jönköping Region, Jönköping, Sweden.
  • Buda S; Robert Koch Institute, Berlin, Germany.
  • Schilling J; Robert Koch Institute, Berlin, Germany.
  • Filleul L; Santé publique France - Direction des régions, Cellule régionale Nouvelle Aquitaine, Bordeaux, France.
  • Lepoutre A; Santé publique France - Direction des régions, Cellule régionale Ile-de-France, Paris, France.
  • Saura C; Santé publique France - Direction des régions, Cellule régionale Auvergne-Rhône-Alpes, Lyon, France.
  • Mailles A; Santé Publique France - Direction des maladies infectieuses, Saint-Maurice, France.
  • Levy-Bruhl D; Santé Publique France - Direction des maladies infectieuses, Saint-Maurice, France.
  • Coignard B; Santé Publique France - Direction des maladies infectieuses, Saint-Maurice, France.
  • Bernard-Stoecklin S; Santé Publique France - Direction des maladies infectieuses, Saint-Maurice, France.
  • Behillil S; Centre national de référence Virus des infections respiratoires, dont la grippe, Institut Pasteur, Paris, France.
  • van der Werf S; Centre national de référence Virus des infections respiratoires, dont la grippe, Institut Pasteur, Paris, France.
  • Valette M; Centre national de référence Virus des infections respiratoires, dont la grippe, Hospices civils de Lyon, Lyon, France.
  • Lina B; Centre national de référence Virus des infections respiratoires, dont la grippe, Hospices civils de Lyon, Lyon, France.
  • Riccardo F; Istituto Superiore di Sanita, Rome, Italy.
  • Nicastri E; Istituto Nazionale Malattie Infettive Lazzaro Spallanzani, Rome, Italy.
  • Casas I; National Centre for Microbiology, WHO-National Influenza Centre, Institute of Health Carlos III. Madrid, Spain.
  • Larrauri A; National Centre of Epidemiology, CIBERESP, Institute of Health Carlos III. Madrid, Spain.
  • Salom Castell M; Dirección General de Salut Pública, Islas Baleares, Spain.
  • Pozo F; National Centre for Microbiology, WHO-National Influenza Centre, Institute of Health Carlos III. Madrid, Spain.
  • Maksyutov RA; State Research Center of Virology and Biotechnology "Vector", Rospotrebnadzor, Moscow, Russia.
  • Martin C; St. Pierre Hospital, Brussels, Belgium.
  • Van Ranst M; Laboratory of Clinical Virology, Department of Microbiology and Immunology, Rega Institute, KU Leuven - University of Leuven, Leuven, Belgium.
  • Bossuyt N; Epidemiology of infectious diseases, Sciensano, Brussels, Belgium.
  • Siira L; Expert Microbiology Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
  • Sane J; Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
  • Tegmark-Wisell K; Public Health Agency of Sweden, Solna, Sweden.
  • Palmérus M; Jönköping Region, Jönköping, Sweden.
  • Broberg EK; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Beauté J; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Jorgensen P; World Health Organisation Regional Office for Europe, Copenhagen, Denmark.
  • Bundle N; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Pereyaslov D; World Health Organisation Regional Office for Europe, Copenhagen, Denmark.
  • Adlhoch C; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Pukkila J; World Health Organisation Regional Office for Europe, Copenhagen, Denmark.
  • Pebody R; World Health Organisation Regional Office for Europe, Copenhagen, Denmark.
  • Olsen S; World Health Organisation Regional Office for Europe, Copenhagen, Denmark.
Euro Surveill ; 25(9)2020 03.
Article em En | MEDLINE | ID: mdl-32156327
ABSTRACT
In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020. We detail the first European cases. As at 21 February, nine European countries reported 47 cases. Among 38 cases studied, 21 were linked to two clusters in Germany and France, 14 were infected in China. Median case age was 42 years; 25 were male. Late detection of the clusters' index cases delayed isolation of further local cases. As at 5 March, there were 4,250 cases.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Vigilância da População / Infecções por Coronavirus / Betacoronavirus Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Asia / Europa Idioma: En Revista: Euro Surveill Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Vigilância da População / Infecções por Coronavirus / Betacoronavirus Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Asia / Europa Idioma: En Revista: Euro Surveill Ano de publicação: 2020 Tipo de documento: Article